Cas No.: | 2078047-42-2 |
Chemical Name: | [1,1'-Biphenyl]-4-carboxamide, N-[(1S)-1-[[[(3-chlorophenyl)methyl]amino]carbonyl]-5-[[(1R,2S)-2-phenylcyclopropyl]amino]pentyl]- |
Synonyms: | NCD38;NCD 38 |
Formula: | C37H37ClF3N3O4 |
M.Wt: | 680.165 |
Purity: | >98% |
Sotrage: | 2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO |
Description: | NCD-38 is a novel potent, selective LSD1 inhibitor with IC50 of 0.59 uM, exerts highly selective inhibitory activity on LSD1 but no other enzymes, such as MAO (IC50>100 uM); inhibits the growth of MLL-AF9 leukemia as well as erythroleukemia, megakaryoblastic leukemia and myelodysplastic syndromes (MDSs) overt leukemia cells. |